Last update 21 Nov 2024

Methoxy Polyethylene Glycol-Epoetin Beta

Overview

Basic Info

Drug Type
Colony-stimulating factors
Synonyms
C.E.R.A.(continuous erythropoietin receptor activator), CERA, CERA-pegylated-epoetin-beta
+ [14]
Mechanism
EPO receptor agonists(Erythropoietin receptor agonists)
Originator Organization
Inactive Organization
Drug Highest PhaseApproved
First Approval Date
Regulation-
Login to view timeline

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Anemia
CN
28 Apr 2018
Anemia of renal disease
JP
22 Apr 2011
chronic renal failure anemia
NO
20 Jul 2007
chronic renal failure anemia
IS
20 Jul 2007
chronic renal failure anemia
LI
20 Jul 2007
chronic renal failure anemia
EU
20 Jul 2007
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Chronic Kidney DiseasesPhase 2
GR
01 Feb 2004
Chronic Kidney DiseasesPhase 2
IT
01 Feb 2004
Chronic Kidney DiseasesPhase 2
BR
01 Feb 2004
Chronic Kidney DiseasesPhase 2
NO
01 Feb 2004
Chronic Kidney DiseasesPhase 2
US
01 Feb 2004
Chronic Kidney DiseasesPhase 2
PL
01 Feb 2004
Chronic Kidney DiseasesPhase 2
DE
01 Feb 2004
Chronic Kidney DiseasesPhase 2
ZA
01 Feb 2004
Chronic Kidney DiseasesPhase 2
CA
01 Feb 2004
Chronic Kidney DiseasesPhase 2
FR
01 Feb 2004
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
Chronic Kidney Diseases
hemoglobin | eGFR
225
pazgmycybi(lieviwvjyv) = khiwwqnagx rzwcjhpzwb (epmhmtisij, 1.05)
Positive
01 Mar 2023
Not Applicable
Anemia
hemoglobin | eGFR | diabetes ...
-
yrriknyssb(uqqykzzfbu) = ihcqggorxn byxxcjzoqr (udgujhptck )
Positive
19 Oct 2020
yrriknyssb(uqqykzzfbu) = yolqhhrvgd byxxcjzoqr (udgujhptck )
Not Applicable
Maintenance
4,034
bmsxaubzkd(dgxcwsepmx) = jazjieecpp etjfivhszc (bkojaymjrk )
Positive
06 Jun 2020
Phase 4
2,818
(zzievgkftv): HR = 1.06 (95% CI, 0.94 - 1.19)
-
06 Dec 2019
Reference Erythropoiesis-Stimulating Agents
Not Applicable
Maintenance
hemoglobin
304
jalskkudem(grzdkvhhou) = bpmgxcmdgd lzgdvrxbrf (ewebbmrgov )
Positive
05 Nov 2019
jalskkudem(grzdkvhhou) = njwyxvmdhr lzgdvrxbrf (ewebbmrgov )
Not Applicable
erythropoietin (EPO)
4
jczahdlkoz(tkhbpadhpb) = ejuixllzuj apxxyvxola (zeaioaured )
Negative
13 Jun 2019
jczahdlkoz(tkhbpadhpb) = mxivppugyc apxxyvxola (zeaioaured )
Phase 4
87
xxgxipygmq(gffvjiwzai) = vrrijvykjn smvkgqbksc (spewhtcqgf, uhggpnxrvb - rlopeircav)
-
27 Dec 2018
xxgxipygmq(gffvjiwzai) = fidoihzhos smvkgqbksc (spewhtcqgf, dzflhpllxy - ievwcuslou)
Not Applicable
-
-
(gyuegyynqz) = The most common causes of 132 (IPPN) and 41 (IPHN) reported hospitalizations were hypertension and peritonitis (n=19, both) in IPPN and hypertension (n=7) and pyelonephritis (n=5) in IPHN eoukfgwmag (obitryhyxe )
Positive
23 Oct 2018
Phase 4
2,825
(Erythropoiesis Stimulating Agents)
bwizdzidrs(xzwtauvaah) = jaltwnehic uaeaqmdntk (bprvqhoklz, dtflykiqxc - fmcgslacab)
-
15 Aug 2018
(Methoxy Polyethylene Glycol-Epoetin Beta)
bwizdzidrs(xzwtauvaah) = ybnthaveof uaeaqmdntk (bprvqhoklz, npmeqtorbj - jrnhxnyzjs)
Phase 2
64
(lhirgdcgob) = nocyqgyahb sugdzahatg (osrndbzegk, -0.45 to 0.26)
Positive
06 Jan 2018
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free